IP Library Granted Patent US 7,582,735
Granted Patent B2
US 7,582,735 · App. 11/676,048 · Granted Sep 1, 2009

Feline immunoglobulin E molecules and related methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,582,735
App. No.
11/676,048
Granted
Sep 1, 2009
Kind
B2
Abstract

The invention relates to: nucleic acid molecules encoding the light chain and heavy chain of feline immunoglobulin E (IgE), including species-specific regions of feline IgE; proteins encoded by the nucleic acid molecules; inhibitors to the nucleic acids and proteins; antibodies to the proteins; cells transformed with the nucleic acid molecules; assays employing the transformed cells, nucleic acids, antibodies and/or proteins or portions thereof; methods for treating IgE-mediated responses (ie. allergy) using the materials provided; methods for eliciting an immune response to IgE and kits containing the nucleic acid molecules, proteins or derivatives thereof (ie. antibodies).

Claims (10)

1. An isolated protein comprising the amino acid sequence encoded by the nucleic acid sequence selected from the group consisting of SEQ ID NO:1, and SEQ ID NO:13.

2. A composition comprising the isolated protein of claim 1 .

3. A kit comprising the isolated protein of claim 1 .

4. An isolated protein comprising the amino acid sequence selected from the group consisting of SEQ ID NO:2, and SEQ ID NO:14.

5. A composition comprising the isolated protein of claim 4 .

6. A kit comprising the isolated protein of claim 4 .

7. An isolated protein produced by a method comprising:

(a) obtaining a recombinant cell comprising a nucleic acid molecule comprising the nucleic acid sequence encoding SEQ ID NO:2, or SEQ ID NO:14, wherein said nucleic acid molecule is operatively linked to an expression vector;

(b) culturing said cell under conditions suitable for causing expression from said nucleic acid molecule; and

(c) recovering said protein.

Assignments (1)
SECURITY AGREEMENT Recorded Feb 26, 2009
From: HESKA CORPORATION
To: WELLS FARGO BUSINESS CREDIT, INC.
Reel/Frame 022354/0170 →